SCHEMBL7317445

SCHEMBL7317445

CCOc1ccc(S(=O)(=O)c2c(C)c(N)c(C)c(Cc3ccccc3)c2C(=O)NO)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 8/20 0.45
ADAM17 P78536 5/20 0.45
MMP1 P03956 4/20 0.45
KEAP1 Q14145 1/20 0.40
MMP9 P14780 7/20 0.39
MAPT P10636 4/20 0.39
TP53 P04637 1/20 0.39
THRB P10828 1/20 0.39
GAA P10253 1/20 0.39
MMP2 P08253 4/20 0.39
MMP14 P50281 4/20 0.39
MMP8 P22894 3/20 0.39
MMP12 P39900 3/20 0.39
MMP16 P51512 3/20 0.39
MMP3 P08254 2/20 0.39
ADAMTS4 O75173 1/20 0.39
ADAMTS5 Q9UNA0 1/20 0.39
CNR2 P34972 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7316684 0.93 MMP9 (0.46) MMP13ADAM17MMP1MMP9MMP2
SCHEMBL7319249 0.93 MMP13 (0.43) MMP13ADAM17MMP1MMP9MAPT
SCHEMBL7323399 0.90 MMP9 (0.49) MMP13ADAM17MMP1MMP9TP53
SCHEMBL7313417 0.88 CNR2 (0.39) MMP13ADAM17MMP1MMP9MMP2
SCHEMBL7317152 0.86 MMP1 (0.38) MMP13ADAM17MMP1MMP9MAPT
SCHEMBL7310752 0.86 MMP9 (0.47) MMP13ADAM17MMP1MMP9MMP2
SCHEMBL7315893 0.85 MMP13 (0.47) MMP13ADAM17MMP1MMP9GAA
SCHEMBL7325559 0.83 CA1 (0.47) MMP13ADAM17MMP1MMP9MMP2
SCHEMBL7325505 0.83 MMP9 (0.46) MMP13ADAM17MMP1MMP9TP53
SCHEMBL7319004 0.82 MMP9 (0.48) MMP13ADAM17MMP1MMP9TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5929097-A INHIBIT TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME AMERICAN CYANAMID COMPANY (US) 1999-07-27 US disclosed